DAVID ADLER: Open Payments
NPI 1346992138 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 9 payments from 4 companies in 2025. Trend: 2023 $229 · 2024 $101 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $158 |
| Amgen Inc. | 4 | $139 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: EVENITY, LINZESS, MYFEMBREE, LILETTA, VAXELIS.
Industry payments across CA — which companies pay providers there.
